BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 3916499)

  • 21. Activation of intravascular macrophages within myocardial small vessels is a feature of acute vascular rejection in human heart transplants.
    Ratliff NB; McMahon JT
    J Heart Lung Transplant; 1995; 14(2):338-45. PubMed ID: 7779854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA-DR antigens in epithelioid cell granulomas of sarcoidosis, using semithin frozen sections. A concept about granuloma formation.
    v Maarsseveen T; Mullink R; Rensen R; Stam J
    Sarcoidosis; 1985 Sep; 2(2):148-53. PubMed ID: 2436274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Donor-derived human leukocyte antigen class I proteins in the serum of heart transplant recipients.
    DeVito-Haynes LD; Jankowska-Gan E; Heisey D; Jutte NH; Balk AH; Weimar W; Claas FH; Warner TF; Mentzer RM; Love RB; Burlingham WJ
    J Heart Lung Transplant; 1996 Oct; 15(10):1012-26. PubMed ID: 8913919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship of increased levels of circulating intercellular adhesion molecule 1 after heart transplantation to rejection: human leukocyte antigen mismatch and survival.
    Ballantyne CM; Mainolfi EA; Young JB; Windsor NT; Cocanougher B; Lawrence EC; Pollack MS; Entman ML; Rothlein R
    J Heart Lung Transplant; 1994; 13(4):597-603. PubMed ID: 7947875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HLA-DR expression in fine-needle aspiration biopsy cell samples as a marker of rejection in kidney grafts.
    Goldberg J; Rial M; Casadei D; Vila N; Zarazaga CN; Mainetti L
    Transplant Proc; 1988 Aug; 20(4):612-3. PubMed ID: 3043816
    [No Abstract]   [Full Text] [Related]  

  • 26. Ten-year experience with endomyocardial biopsy in myocarditis presenting with congestive heart failure: frequency, pathologic characteristics, treatment and follow-up.
    Arbustini E; Gavazzi A; Dal Bello B; Morbini P; Campana C; Diegoli M; Grasso M; Fasani R; Banchieri N; Porcu E; Pilotto A; Ponzetta M; Bellini O; Lucreziotti S; Viganò M
    G Ital Cardiol; 1997 Mar; 27(3):209-23. PubMed ID: 9199949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive value of inducible endothelial cell adhesion molecule expression for acute rejection of human cardiac allografts.
    Briscoe DM; Yeung AC; Schoen FJ; Allred EN; Stavrakis G; Ganz P; Cotran RS; Pober JS; Schoen EL
    Transplantation; 1995 Jan; 59(2):204-11. PubMed ID: 7530872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Additive value of immunologic monitoring to histologic grading of heart allograft biopsy specimens: implications for therapy.
    Fisher PE; Suciu-Foca N; Ho E; Michler RE; Rose EA; Mancini D
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1156-61. PubMed ID: 8719463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temporal reduction in acute rejection after heart transplantation is not associated with a reduction in cell-mediated responses to donor-specific vascular endothelium.
    Hosenpud JD; Shipley GD; Mauck KA; Morris TE; Wagner CR
    J Heart Lung Transplant; 1995; 14(5):926-37. PubMed ID: 8800729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitation of cytomegalovirus infection-associated histologic findings in endomyocardial biopsies of heart allografts.
    Koskinen PK; Krogerus LA; Nieminen MS; Mattila SP; Häyry PJ; Lautenschlager IT
    J Heart Lung Transplant; 1993; 12(3):343-54. PubMed ID: 8392371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular abnormalities and cardiomyocyte lipofuscin deposits in endomyocardial biopsy specimens of heart transplant recipients: are they related to the development of cardiac allograft vasculopathy?
    Zakliczynski M; Nozynski J; Konecka-Mrowka D; Krynicka-Mazurek A; Swierad M; Maruszewski M; Przybylski R; Zembala M
    J Thorac Cardiovasc Surg; 2009 Jul; 138(1):215-21, 221.e1-3. PubMed ID: 19577082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Late onset antibody-mediated rejection and endothelial localization of vascular endothelial growth factor are associated with development of cardiac allograft vasculopathy.
    Bayliss J; Bailey M; Leet A; Stein AN; Thomson NM; McLean CA
    Transplantation; 2008 Oct; 86(7):991-7. PubMed ID: 18852667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HLA-DR expression in bile duct damage in hepatitis C.
    Danque PO; Bach N; Schaffner F; Gerber MA; Thung SN
    Mod Pathol; 1993 May; 6(3):327-32. PubMed ID: 8346181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coexpression of aspartic proteinases and human leukocyte antigen-DR in human transplanted lung.
    Arbustini E; Morbini P; Diegoli M; Grasso M; Fasani R; Vitulo P; Fiocca R; Cremaschi P; Volpato G; Martinelli L
    Am J Pathol; 1994 Aug; 145(2):310-21. PubMed ID: 8053491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of the inflammatory process by endomyocardial biopsy in patients with dilated cardiomyopathy based on pathological and immunohistochemical methods.
    Prochorec-Sobieszek M; Bilińska ZT; Grzybowski J; Mazurkiewicz L; Skwarek M; Walczak E; Michalak E; Cedro K; Chmielak Z; Debski A; Demkow M; Witkowski A; Wagner T; Ruzyłło W
    Kardiol Pol; 2006 May; 64(5):479-87; discussion 488. PubMed ID: 16752331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
    Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
    J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoglobulin M-to-immunoglobulin G anti-human leukocyte antigen class II antibody switching in cardiac transplant recipients is associated with an increased risk of cellular rejection and coronary artery disease.
    Lietz K; John R; Burke E; Schuster M; Rogers TB; Suciu-Foca N; Mancini D; Itescu S
    Circulation; 2005 Oct; 112(16):2468-76. PubMed ID: 16230499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activated cells in urine and monocyte chemotactic peptide-1 (MCP-1)--sensitive rejection markers in renal graft recipients.
    Dubiński B; Boratyńska M; Kopeć W; Szyber P; Patrzałek D; Klinger M
    Transpl Immunol; 2008 Jan; 18(3):203-7. PubMed ID: 18047927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclosporine does not abrogate donor-specific class II expression in allografted human heart.
    Rose M; Navarette C; Yacoub M; Festenstein H
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):333-40. PubMed ID: 3291265
    [No Abstract]   [Full Text] [Related]  

  • 40. HLA-A,B,C, and HLA-DR antigens and dendritic cells in fresh and organ culture preserved corneas.
    Pels E; van der Gaag R
    Cornea; 1984-1985; 3(4):231-9. PubMed ID: 6599840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.